• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ARNA

ARNA

Arena Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

Company Profile

CEO

Amit Munshi

IPO Date

2000-07-28

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

28.1%

Avg Negative

12.5%

Avg Neutral

59.4%

News Feed

Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/5/2021·↓ negative

Arena Pharmaceuticals, Inc. (ARNA) Reports Q2 Loss, Lags Revenue Estimates

Zacks Investment Research·8/5/2021·↑ positive

Arena's (ARNA) Etrasimod Gets FDA's Orphan Drug Tag for EoE

Zacks Investment Research·6/10/2021·↑ positive

Arena (ARNA) Starts Phase II Study on Coronary Drug Temanogrel

Zacks Investment Research·6/9/2021·↑ positive

Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of Eosinophilic Esophagitis (EoE)

Business Wire·6/9/2021·↑ positive

Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/5/2021·↓ negative

Arena Pharmaceuticals, Inc. (ARNA) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research·5/5/2021·↑ positive

Arena Pharmaceuticals, Inc. (ARNA) Down 12.2% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research·3/25/2021·↓ negative

3 Reasons to Avoid Arena Pharmaceuticals -- and 1 Reason to Buy

The Motley Fool·3/16/2021·↑ positive

Arena (ARNA) Q4 Earnings Miss Estimates, Pipeline Progresses

Zacks Investment Research·2/24/2021·↓ negative